Sight Sciences Inc SGHT Q1 2026 Earnings WiderThanExpected Loss Drags Stock Down Over 2 Calidi Biotherapeutics Q4 2025 Earnings Narrowed Loss Surprises Stock Declines ONL Q1 2026 Earnings Significant EPS Miss as Losses Widen ISBA Q1 2026 Earnings Significant EPS Miss and Negative Surprise CR Q1 2026 Earnings Strong EPS Beat Despite Modest Stock Reaction Design Therapeutics Inc DSGN Q1 2026 Earnings Narrower Loss Surpasses Expectations Amid Quiet Quarter